1. Home
  2. III vs VYGR Comparison

III vs VYGR Comparison

Compare III & VYGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Information Services Group Inc.

III

Information Services Group Inc.

HOLD

Current Price

$4.13

Market Cap

193.7M

ML Signal

HOLD

Logo Voyager Therapeutics Inc.

VYGR

Voyager Therapeutics Inc.

HOLD

Current Price

$3.00

Market Cap

203.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
III
VYGR
Founded
2006
2013
Country
United States
United States
Employees
1500
N/A
Industry
Professional Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
193.7M
203.6M
IPO Year
2006
2015

Fundamental Metrics

Financial Performance
Metric
III
VYGR
Price
$4.13
$3.00
Analyst Decision
Buy
Strong Buy
Analyst Count
1
2
Target Price
$5.50
$16.50
AVG Volume (30 Days)
195.4K
748.0K
Earning Date
05-07-2026
05-08-2026
Dividend Yield
4.46%
N/A
EPS Growth
216.67
N/A
EPS
0.05
N/A
Revenue
$192,745,000.00
$10,135,000.00
Revenue This Year
$3.85
$34.04
Revenue Next Year
$4.34
$7.92
P/E Ratio
$80.30
N/A
Revenue Growth
4.51
N/A
52 Week Low
$3.74
$2.88
52 Week High
$6.45
$5.55

Technical Indicators

Market Signals
Indicator
III
VYGR
Relative Strength Index (RSI) 54.57 34.98
Support Level $3.88 $2.96
Resistance Level $4.33 $4.33
Average True Range (ATR) 0.15 0.18
MACD 0.01 -0.02
Stochastic Oscillator 81.72 5.19

Price Performance

Historical Comparison
III
VYGR

About III Information Services Group Inc.

Information Services Group Inc is an AI-centered technology research and advisory firm providing digital transformation and technology advisory services that help organizations optimize performance, reduce costs, and accelerate innovation. The Company's expertise includes sourcing advisory, cloud and data analytics, managed governance and risk services, network and software advisory, technology strategy and operations design, change management, and market intelligence, serving both private- and public-sector clients globally. It operates in one segment, fact-based sourcing advisory services, and operates principally in the Americas, with generate maximum revenue in Europe and the Asia Pacific.

About VYGR Voyager Therapeutics Inc.

Voyager Therapeutics Inc is a biotechnology company to leverage the power of human genetics to modify the course of and ultimately cure neurological diseases. Its pipeline includes programs for Alzheimer's disease, or AD; Friedreich's ataxia, or FA; Parkinson's disease, or PD; and multiple other diseases of the central nervous system, or CNS. Many of its programs are derived from its TRACER (Tropism Redirection of AAV by Cell-type-specific Expression of RNA) adeno-associated virus, or AAV, capsid discovery platform, which the company has used to generate novel capsids, or TRACER Capsids, and identify associated receptors to potentially enable high brain penetration with genetic medicines following intravenous, or IV, dosing. Its segment is developing and commercializing genetic medicine.

Share on Social Networks: